Victory Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.35M | Sell |
132,630
-17,630
| -12% | -$179K | ﹤0.01% | 1715 |
|
|
2025
Q1 | $838K | Buy |
150,260
+52,760
| +54% | +$294K | ﹤0.01% | 1879 |
|
|
2024
Q4 | $787K | Sell |
97,500
-2,250
| -2% | -$18.2K | ﹤0.01% | 1902 |
|
|
2024
Q3 | $1.02M | Buy |
99,750
+3,900
| +4% | +$40K | ﹤0.01% | 1768 |
|
|
2024
Q2 | $678K | Buy |
95,850
+7,310
| +8% | +$51.7K | ﹤0.01% | 1881 |
|
|
2024
Q1 | $1.22M | Sell |
88,540
-37,490
| -30% | -$515K | ﹤0.01% | 1646 |
|
|
2023
Q4 | $1.16M | Buy |
126,030
+1,180
| +0.9% | +$10.9K | ﹤0.01% | 1646 |
|
|
2023
Q3 | $755K | Sell |
124,850
-12,180
| -9% | -$73.7K | ﹤0.01% | 1804 |
|
|
2023
Q2 | $1.06M | Sell |
137,030
-21,400
| -14% | -$166K | ﹤0.01% | 1645 |
|
|
2023
Q1 | $903K | Buy |
+158,430
| New | +$903K | ﹤0.01% | 1754 |
|
|
2022
Q4 | – | Sell |
-47,479
| Closed | -$152K | – | 2679 |
|
|
2022
Q3 | $152K | Sell |
47,479
-479
| -1% | -$1.53K | ﹤0.01% | 2400 |
|
|
2022
Q2 | $215K | Buy |
47,958
+39
| +0.1% | +$175 | ﹤0.01% | 2328 |
|
|
2022
Q1 | $159K | Sell |
47,919
-1,757,798
| -97% | -$5.83M | ﹤0.01% | 2444 |
|
|
2021
Q4 | $26.5M | Buy |
1,805,717
+259,394
| +17% | +$3.81M | 0.02% | 810 |
|
|
2021
Q3 | $32.3M | Buy |
1,546,323
+241,963
| +19% | +$5.06M | 0.03% | 703 |
|
|
2021
Q2 | $23.1M | Buy |
1,304,360
+198,986
| +18% | +$3.52M | 0.02% | 850 |
|
|
2021
Q1 | $27.1M | Buy |
1,105,374
+5,081
| +0.5% | +$124K | 0.03% | 792 |
|
|
2020
Q4 | $37.2M | Buy |
1,100,293
+203,159
| +23% | +$6.88M | 0.04% | 626 |
|
|
2020
Q3 | $22.4M | Buy |
897,134
+329,014
| +58% | +$8.23M | 0.03% | 742 |
|
|
2020
Q2 | $19.2M | Buy |
+568,120
| New | +$19.2M | 0.03% | 802 |
|